HW
FBIO icon

Hancock Whitney’s Fortress Biotech FBIO Stock Holding History

Hancock Whitney’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,191
Closed -$133K – 810
2020
Q3 		$133K Sell
2,191
-545
-20% -$27.8K ﹤0.01% 729
2020
Q2 		$110K Buy
+2,736
New +$102K ﹤0.01% 757

Other funds holding FBIO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return

Hancock Whitney's FBIO Position: Q4 2020 in Review

Hancock Whitney sold out of Fortress Biotech (FBIO) in Q4 2020, closing a stake of 2,191 shares — an estimated $133K sold.

Hancock Whitney first reported a position in FBIO in Q2 2020 and held it in 2 quarters. The position peaked at $133K in Q3 2020. 87 funds tracked by Wall St. Rank hold FBIO as of Q4 2020.

  • Hancock Whitney reported no remaining Fortress Biotech position as of Q4 2020 after selling out during the quarter.
  • Hancock Whitney sold 2,191 Fortress Biotech shares in Q4 2020, an estimated $133K.
  • Hancock Whitney first reported a position in Fortress Biotech in Q2 2020 and held it in 2 quarters.
  • Hancock Whitney's Fortress Biotech position peaked at $133K in Q3 2020.
  • 87 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2020.

Based on Hancock Whitney's 13F filing for Q4 2020, filed 9 Feb 2021.